| Identification | Back Directory | [Name]
3''-PRENYLDAIDZEIN | [CAS]
41060-15-5 | [Synonyms]
Neobavaisoavone
Neobavaisoflavone, >99%
4',7-Dihydroxy-3'-(3-methyl-2-butenyl)isoflavone
Neobavaisoflavone, 98%, from Psoralea corylifolia L.
7-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromen-4-one
7-Hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)phenyl)-4H-chromen-4-one
7-Hydroxy-3-(4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl)-4H-chromen-4-one
7-Hydroxy-3-[4-hydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-4H-1-benzopyran-4-one
4H-1-Benzopyran-4-one, 7-hydroxy-3-[4-hydroxy-3-(3-methyl-2-buten-1-yl)phenyl]- | [Molecular Formula]
C20H18O4 | [MDL Number]
MFCD00800660 | [MOL File]
41060-15-5.mol | [Molecular Weight]
322.35 |
| Chemical Properties | Back Directory | [Melting point ]
195-196℃ | [Boiling point ]
545.0±50.0 °C(Predicted) | [density ]
1.279 | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [solubility ]
DMF: 20 mg/mL; DMF:PBS (pH 7.2) (1:4): 0.1 mg/mL; DMSO: 10 mg/mL; Ethanol: 1 mg/mL | [form ]
Yellow solid. | [pka]
6.92±0.20(Predicted) | [color ]
White to Light yellow to Light orange | [λmax]
300nm(lit.) |
| Hazard Information | Back Directory | [Chemical Properties]
White needle-shaped crystals, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from the fruit of Psoralea corylifolia. | [Uses]
Inhibits platelet aggregation. DNA polymerase inhibitor. Shows antifungal activity. | [Definition]
ChEBI: Neobavaisoflavone is a member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone with an additonal hydroxy group at position 4' and a prenyl group at position 3'. Isolated from seeds of Psoralea corylifolia, it exhibits inhibitory activity against DNA polymerase and platelet aggregation. It has a role as a platelet aggregation inhibitor, an antineoplastic agent, a plant metabolite and an EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor. | [in vivo]
Neobavaisoflavone (30 mg/kg; i.p. for 6 weeks) inhibits osteoclastogenesis, promotes osteogenesis and ameliorates bone loss in ovariectomized mice[3]. | Animal Model: | C57BL/6 female mice (8 weeksd; 20-25 g) were removed bilateral ovaries[3] | | Dosage: | 30 mg/kg | | Administration: | I.p. for 6 weeks | | Result: | Attenuated bone loss by inhibiting osteoclast activation and promoting osteogenesis in ovariectomized mice. |
| [storage]
Store at -20°C |
|
| Company Name: |
China Langchem Inc.
|
| Telephone: |
0086-21-58956006 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList19141/0_EN.htm |
|